Bromfenac

CHEMBL1077 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
334.2 g/mol
LogP
3.3
Phase
4

A nonsteroidal anti-inflammatory drug formulated as eye drops to reduce pain and inflammation following cataract surgery. It works by inhibiting cyclooxygenase enzymes in the eye to block prostaglandin production. Its twice-daily or once-daily dosing schedule improves convenience for patients recovering from eye surgery.

Peso molecular

334,1600 g/mol

LogP

3,30

TPSA

80,40 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1

InChI

InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)

Molecular Formula

C15H12BrNO3

HBD / HBA

2 / 4

Enlaces Rotables

4

Átomos Pesados

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A nonsteroidal anti-inflammatory drug formulated as eye drops to reduce pain and inflammation following cataract surgery. It works by inhibiting cyclooxygenase enzymes in the eye to block prostaglandin production. Its twice-daily or once-daily dosing schedule improves convenience for patients recovering from eye surgery.

Yes, Bromfenac is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1077. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 60726. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.